PD1-Expressing T Cell Subsets Modify the Rejection Risk in Renal Transplant Patients
Open Access
- 11 April 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 7, 126
Abstract
We tested whether multi-parameter immune phenotyping before or after renal transplantation can predict the risk of rejection episodes. Blood samples collected before, and weekly for 3 months after transplantation were analyzed by multi-parameter flow-cytometry to define 52 T cell and 13 innate lymphocyte subsets in each sample, producing more than 11,000 data points that defined the immune status of the 28 patients included in this study. Principle component analysis suggested that the patients with histologically confirmed rejection episodes segregated from those without rejection. Protein death 1 (PD-1)-expressing subpopulations of regulatory and conventional T cells had the greatest influence on the principal component segregation. We constructed a statistical tool to predict rejection using a support vector machine algorithm. The algorithm correctly identified 7 out of 9 patients with rejection, and 14 out of 17 patients without rejection. The immune profile before transplantation was most accurate in determining the risk of rejection, while changes of immune parameters after transplantation were less accurate in discriminating rejection from non-rejection. The data indicate that pre-transplant immune subset analysis has the potential to identify patients at risk of developing rejection episodes, and suggests that the proportion of PD1-expressing T cell subsets may be a key indicator of rejection risk.Keywords
Funding Information
- Leukaemia and Lymphoma Research (13004)
- Medical Research Council (G00321)
This publication has 20 references indexed in Scilit:
- Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell TypesScience, 2014
- Pretransplantation Soluble CD30 Level As a Predictor of Acute Rejection in Kidney TransplantationTransplantation, 2012
- Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulatorsNature Biotechnology, 2012
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivoProceedings of the National Academy of Sciences, 2012
- PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCVJournal of Clinical Investigation, 2009
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Restoring function in exhausted CD8 T cells during chronic viral infectionNature, 2005
- CD4 + CD25 + Regulatory Cells from Human Peripheral Blood Express Very High Levels of CD25 Ex Vivo2003
- Characterizing Graph Drawing with EigenvectorsJournal of Chemical Information and Computer Sciences, 2000